Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Oral supplementation with branched-chain amino acid granules prevents hepatocarcinogenesis in patients with hepatitis C-related cirrhosis: A propensity score analysis.

Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabatake S, Niinomi T, Ito T, Hasegawa R, Ando Y, Yamamoto K, Tanaka T.

Hepatol Res. 2014 Mar;44(3):288-95. doi: 10.1111/hepr.12120. Epub 2013 Apr 29.

PMID:
23607436
2.

Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.

Hayaishi S, Chung H, Kudo M, Ishikawa E, Takita M, Ueda T, Kitai S, Inoue T, Yada N, Hagiwara S, Minami Y, Ueshima K.

Dig Dis. 2011;29(3):326-32. doi: 10.1159/000327571. Epub 2011 Aug 9.

PMID:
21829025
3.

Impact of the branched-chain amino acid to tyrosine ratio and branched-chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis.

Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabatake S, Yama T.

J Gastroenterol Hepatol. 2015 Sep;30(9):1412-9. doi: 10.1111/jgh.12954.

PMID:
25799910
4.

The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation.

Nishikawa H, Osaki Y, Iguchi E, Koshikawa Y, Ako S, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A, Henmi S, Hatamaru K, Ishikawa T, Saito S, Nasu A, Kita R, Kimura T.

J Clin Gastroenterol. 2013 Apr;47(4):359-66. doi: 10.1097/MCG.0b013e31826be9ad.

PMID:
23090049
5.

Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis.

Kawaguchi T, Shiraishi K, Ito T, Suzuki K, Koreeda C, Ohtake T, Iwasa M, Tokumoto Y, Endo R, Kawamura NH, Shiraki M, Habu D, Tsuruta S, Miwa Y, Kawaguchi A, Kakuma T, Sakai H, Kawada N, Hanai T, Takahashi S, Kato A, Onji M, Takei Y, Kohgo Y, Seki T, Tamano M, Katayama K, Mine T, Sata M, Moriwaki H, Suzuki K.

Clin Gastroenterol Hepatol. 2014 Jun;12(6):1012-8.e1. doi: 10.1016/j.cgh.2013.08.050. Epub 2013 Sep 10.

PMID:
24036055
6.

Clinical significance of early interventional therapy of branched-chain amino acid granules in patients with hepatocellular carcinoma: propensity score matching analysis.

Nishikawa H, Kita R, Kimura T, Ohara Y, Takeda H, Sakamoto A, Saito S, Nishijima N, Nasu A, Komekado H, Osaki Y.

Int J Oncol. 2014 Sep;45(3):1082-90. doi: 10.3892/ijo.2014.2514. Epub 2014 Jun 24.

PMID:
24969042
7.

Suppressive effect of oral administration of branched-chain amino acid granules on oxidative stress and inflammation in HCV-positive patients with liver cirrhosis.

Ohno T, Tanaka Y, Sugauchi F, Orito E, Hasegawa I, Nukaya H, Kato A, Matunaga S, Endo M, Tanaka Y, Sakakibara K, Mizokami M.

Hepatol Res. 2008 Jul;38(7):683-8. doi: 10.1111/j.1872-034X.2008.00319.x. Epub 2008 Mar 4.

PMID:
18328070
8.

Effect of oral supplementation with branched-chain amino acid granules in the early stage of cirrhosis.

Nishiguchi S, Habu D.

Hepatol Res. 2004 Dec;30S:36-41. Epub 2004 Nov 10.

PMID:
15607137
9.

Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.

Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H; Long-Term Survival Study Group.

Clin Gastroenterol Hepatol. 2005 Jul;3(7):705-13.

PMID:
16206505
10.

Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice.

Iwasa J, Shimizu M, Shiraki M, Shirakami Y, Sakai H, Terakura Y, Takai K, Tsurumi H, Tanaka T, Moriwaki H.

Cancer Sci. 2010 Feb;101(2):460-7. doi: 10.1111/j.1349-7006.2009.01402.x. Epub 2009 Oct 15.

11.

Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis.

Habu D, Nishiguchi S, Nakatani S, Lee C, Enomoto M, Tamori A, Takeda T, Ohfuji S, Fukushima W, Tanaka T, Kawamura E, Shiomi S.

Hepatogastroenterology. 2009 Nov-Dec;56(96):1719-23.

PMID:
20214224
12.

Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis.

Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H, Ohashi Y; Long-Term Survival Study (LOTUS) Group.

Hepatol Res. 2006 Jul;35(3):204-14. Epub 2006 Jun 5.

PMID:
16737844
13.

Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis.

Yoshida T, Muto Y, Moriwaki H, Yamato M.

Gastroenterol Jpn. 1989 Dec;24(6):692-8.

PMID:
2606303
14.

Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.

Cha JH, Bae SH, Kim HL, Park NR, Choi ES, Jung ES, Choi JY, Yoon SK.

PLoS One. 2013 Nov 1;8(11):e77899. doi: 10.1371/journal.pone.0077899. eCollection 2013.

15.

Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study.

Park JG, Tak WY, Park SY, Kweon YO, Jang SY, Lee YR, Bae SH, Jang JY, Kim DY, Lee JS, Suk KT, Kim IH, Lee HJ, Chung WJ, Jang BK, Suh JI, Heo J, Lee WK.

Medicine (Baltimore). 2017 Jun;96(24):e6580. doi: 10.1097/MD.0000000000006580.

16.

Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, Rossi Fanelli F, Abbiati R; Italian BCAA Study Group.

Gastroenterology. 2003 Jun;124(7):1792-801.

PMID:
12806613
17.

Impact of branched-chain amino acid supplementation on survival in patients with advanced hepatocellular carcinoma treated with sorafenib: A multicenter retrospective cohort study.

Imanaka K, Ohkawa K, Tatsumi T, Katayama K, Inoue A, Imai Y, Oshita M, Iio S, Mita E, Fukui H, Yamada A, Nakanishi F, Inada M, Doi Y, Suzuki K, Kaneko A, Marubashi S, Ito Y, Fukui K, Sakamori R, Yakushijin T, Hiramatsu N, Hayashi N, Takehara T; Osaka Liver Forum.

Hepatol Res. 2016 Sep;46(10):1002-10. doi: 10.1111/hepr.12640. Epub 2016 Jan 26.

PMID:
26690886
18.

Role of branched-chain amino acids in management of cirrhosis and hepatocellular carcinoma.

Lam VW, Poon RT.

Hepatol Res. 2008 Nov;38 Suppl 1:S107-15. doi: 10.1111/j.1872-034X.2008.00435.x.

PMID:
19125941
19.

Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial.

Nojiri S, Fujiwara K, Shinkai N, Iio E, Joh T.

Nutrition. 2017 Jan;33:20-27. doi: 10.1016/j.nut.2016.07.013. Epub 2016 Aug 8.

PMID:
27908546

Supplemental Content

Support Center